LeMaitre Vascular (NSDQ:LMAT) posted fourth-quarter results that beat the overall consensus forecast on Wall Street. The Burlington, Massachusetts-based company yesterday evening reported profits of $6.2 million, or 28¢ per share, on sales of $39.5 million for the three months ended Dec. 31, 2021, for a bottom-line loss of -12.2% on sales growth … [Read more...] about LeMaitre Vascular beats The Street in Q4, grows sales 5%
Interrad Medical, Eloquest Healthcare partner to expand SecurAcath sales in U.S.
Interrad Medical this week announced that it formed a strategic partnership with Eloquest Healthcare to expand sales of SecurAcath in the U.S. Through the partnership, the companies will provide hospitals and clinicians with Interred Medical's SecurAcath to improve outcomes and reduce medical expenses, according to the company. “We are … [Read more...] about Interrad Medical, Eloquest Healthcare partner to expand SecurAcath sales in U.S.
Teleflex wins FDA clearance for expanded indications of CTO specialty catheters, guidewires
Teleflex (NYSE:TFX) today announced that it received FDA clearance for expanded indication for its specialty catheters and coronary guidewires for use in crossing chronic total occlusion percutaneous coronary interventions (CTO PCI). Devices that are included in the expanded indication are the Teleflex GuideLiner V3 catheter, TrapLiner catheter, … [Read more...] about Teleflex wins FDA clearance for expanded indications of CTO specialty catheters, guidewires
Penumbra posts mixed-bag Q4 results, grows sales 22%
Penumbra (NYSE:PEN) this week posted fourth-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. The Alameda, California-based company reported losses of -$24.6 million, or -66¢ per share, on sales of $204 million for the three months ended Dec. 31, 2021, for a sales growth of 22.24% compared with Q4 … [Read more...] about Penumbra posts mixed-bag Q4 results, grows sales 22%
Front Line Medical expands availability of COBRA-OS arterial occlusion system
Front Line Medical recently announced that it expanded the availability of its COBRA-OS aortic occlusion device to meet growing demands. The Ontario, Canada-based company is increasing production of the COBRA-OS (control of bleeding, resuscitation, arterial occlusion system) occluder following patient success rates and expanded interest from … [Read more...] about Front Line Medical expands availability of COBRA-OS arterial occlusion system
InfuSystem, Solo-Dex sign distribution agreement for nerve block catheters
InfuSystem today announced that it entered a national distribution agreement with Solo-Dex for its continuous nerve block catheters. Solo-Dex's catheter over the needle technology allows anesthesiologists to place facile continuous peripheral block catheters in two to three minutes. It can be used in common procedures such as shoulder repair, … [Read more...] about InfuSystem, Solo-Dex sign distribution agreement for nerve block catheters
MicroVention announces first U.S. clinical case using aneurysm flow diverter Fred X
MicroVention today announced that the first U.S. clinical case of its flow diverter Fred X device was performed at Thomas Jefferson University Hospital in Philadelphia. Aliso Viejo, California-based MicroVention received premarket approval for the Fred X device in September. It uses a self-expanding braided nitinol mesh to redirect blood flow … [Read more...] about MicroVention announces first U.S. clinical case using aneurysm flow diverter Fred X
Medtronic wins FDA expanded approval to use cardiac cryoablation catheters in kids
Medtronic today announced that it received FDA expanded approval for its Freezor and Freezor Xtra cardiac cryoablation catheters for pediatric atrioventricular nodal reentrant tachycardia (AVRNT). AVNRT is the most common form of supraventricular tachycardia and involves a life-threatening abnormal heart rhythm. More than a third of AVRNY cases … [Read more...] about Medtronic wins FDA expanded approval to use cardiac cryoablation catheters in kids
FDA clears EvoEndo’s single-use endoscopy system
EvoEndo today said it received FDA 510(k) clearance for its single-use endoscopy system. Denver-based EvoEndo designed the single-use endoscopy system with a sterile, single-use, flexible endoscope and a portable video controller and take-home "comfort kit" with virtual reality goggles for patient entertainment and distraction during a … [Read more...] about FDA clears EvoEndo’s single-use endoscopy system
AtHeart Medical wins FDA approval for second phase of ASD occluder IDE study
AtHeart Medical recently announced that it received FDA approval to commence the second phase of its Ascent ASD investigational device exemption pivotal trial. Switzerland-based AtHeart Medical is evaluating the safety and efficacy of the reSept atrial septal defects (ASD) occluder in a prospective, single-arm study. The reSept device is … [Read more...] about AtHeart Medical wins FDA approval for second phase of ASD occluder IDE study